Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
44.56 USD | -0.35% | +2.36% | +20.78% |
May. 07 | Halozyme Therapeutics Q1 Non-GAAP Earnings, Revenue Rise; 2024 Guidance Reaffirmed | MT |
May. 07 | Transcript : Halozyme Therapeutics, Inc., Q1 2024 Earnings Call, May 07, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+20.78% | 5.69B | |
+9.72% | 115B | |
+11.68% | 106B | |
-2.59% | 21.96B | |
-13.30% | 21.87B | |
-5.29% | 19.21B | |
-4.27% | 18.08B | |
-38.57% | 17.71B | |
+6.50% | 14.32B | |
+33.98% | 12.42B |
- Stock Market
- Equities
- HALO Stock
- News Halozyme Therapeutics, Inc.
- Earnings Flash (HALO) HALOZYME THERAPEUTICS Reports Q1 EPS $0.79, vs. Street Est of $0.70